Diabetes in Focus: What Every Care Team Needs to Know Right Now

Diabetes in Focus: What Every Care Team Needs to Know Right Now TeeJay is joined by clinical trainer Hollie Carlile for a conversation about diabetes that's equal parts practical and exciting, because as they recorded this episode, a landmark piece of news landed from Diabetes UK that changes the picture for type 1 diabetes in the UK. From the technology reshaping daily monitoring, to breakthrough treatments and what care teams should be watching for in the people they support, this one covers a lot of ground; and all of it matters for care teams supporting people with diabetes in the community. In this episode: Type 1 vs type 2 diabetes explained — and why the line between them is blurring The rise of type 2 in younger people and why processed food and lifestyle play a bigger role than ever Continuous glucose monitoring (CGM) — how Dexcom and Libre work, who they're for, and why they're changing the game The missing million — up to a million people in the UK are living with undiagnosed type 2 diabetes right now. The signs your care team should be watching for Hypos, hypers, and why high blood sugar over time is just as dangerous as a crisis moment Complications of poorly managed diabetes: retinopathy, kidney disease, nerve damage, wound healing, and amputation — and why care teams in the community need to understand the long-term picture GLP-1 medications — what they are, how they work, the weight loss debate, and the new tablet option now available. Plus a serious warning about fake GLP-1s being sold online Breaking news: Teplizumab has just been approved by NICE for NHS use — a drug that can delay the onset of type 1 diabetes by up to three years. TeeJay and Hollie talk about what that means and the new screening programme rolling out for children aged 2–17 Inhaled insulin — not yet available in the UK, but worth watching Talking labels — a small but important piece of tech for people with diabetes-related sight loss managing their own medications Useful links: Diabetes UK risk quiz: https://www.diabetes.org.uk/diabetes-the-basics/diabetes-risk-factors NICE guidance on CGM for type 2 diabetes: Blood glucose management | Type 2 diabetes in adults: management | Guidance | NICE Information on Teplizumab / NHS approval: Teplizumab, the first treatment to slow type 1 diabetes, approved for use on the NHS | Diabetes UK Talking Labels - Talking Labels - Medication Management Labelling Solutions - Blind – Talking Products Ltd